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Abstract
Background: Disruption of thyroid hormone signalling can alter growth, development and energy metabolism.
Thyroid hormones exert their effects through interactions with thyroid receptors that directly bind thyroid response
elements and can alter transcriptional activity of target genes. The effects of short-term thyroid hormone
perturbation on hepatic mRNA transcription in juvenile mice were evaluated, with the goal of identifying genes
containing active thyroid response elements. Thyroid hormone disruption was induced from postnatal day 12 to 15
by adding goitrogens to dams’ drinking water (hypothyroid). A subgroup of thyroid hormone-disrupted pups
received intraperitoneal injections of replacement thyroid hormones four hours prior to sacrifice (replacement). An
additional group received only thyroid hormones four hours prior to sacrifice (hyperthyroid). Hepatic mRNA was
extracted and hybridized to Agilent mouse microarrays.
Results: Transcriptional profiling enabled the identification of 28 genes that appeared to be under direct thyroid
hormone-regulation. The regulatory regions of the genome adjacent to these genes were examined for half-site
sequences that resemble known thyroid response elements. A bioinformatics search identified 33 thyroid response
elements in the promoter regions of 13 different genes thought to be directly regulated by thyroid hormones.
Thyroid response elements found in the promoter regions of Tor1a, 2310003H01Rik, Hect3d and Slc25a45 were
further validated by confirming that the thyroid receptor is associated with these sequences in vivo and that it can
bind directly to these sequences in vitro. Three different arrangements of thyroid response elements were
identified. Some of these thyroid response elements were located far up-stream (> 7 kb) of the transcription start
site of the regulated gene.
Conclusions: Transcriptional profiling of thyroid hormone disrupted animals coupled with a novel bioinformatics
search revealed new thyroid response elements associated with genes previously unknown to be responsive to
thyroid hormone. The work provides insight into thyroid response element sequence motif characteristics.
Background
The thyroid participates in the regulation of basic phy-
siological processes by producing thyroid hormones
(THs), which include thyroxine (T4) and triiodothyro-
nine (T3). THs exert their effects on growth,
development and metabolism of practically every cell
and organ [1]. Their primary effect is the transcriptional
regulation of target genes. This occurs when THs inter-
act with TH receptors (TRs). Similar to other nuclear
receptors, TR contains a DNA-binding domain that is
capable of interacting with specific DNA sequences
known as thyroid response elements (TREs). Typically,
TREs are composed of two or more hexamer half-site
sequences arranged in tandem array. TRs have the abil-
ity to bind to various imperfect TRE half-sites. The
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their orientation are all features that can vary between
TREs [2]. TRs can bind to TREs as monomers or homo-
dimers, although it is thought that TRs interact as het-
erodimers with the retinoid × receptor (RXR) the
majority of the time [3,4].
Disruption of TH physiology during critically sensitive
periods in development can lead to adverse outcomes.
Studies have shown that severe TH insufficiencies lead
to somatic and brain growth retardation [5]. Less severe
and/or transient hypothyroidism has also been shown to
cause adverse structural and functional effects [6,7]. In
humans, subclinical hypothyroidism during fetal devel-
opment has been shown to result in reduced cognitive
function [8].
Exposures to a broad array of substances, including
both natural and synthetic chemicals, have been shown
to alter TH physiology (see [9,10] for review). Environ-
mental contaminants such as perchlorates [11], poly-
chlorinated biphenyls [12], bisphenol A [13],
polybrominated diphenyl ethers [14], triclosan [15] and
nitrate [16] have all been shown to have a negative
effect on TH function, ranging from reducing circulating
THs to altering TH-signalling.
Much effort has been expended to identify direct tran-
scriptional targets of TH [17-19]. Identification of the
thyroid regulated transcriptome will provide insights
into the molecular impact of THs in directing tissue
function/development. We have previously characterized
TH-regulated global gene expression in the livers of
juvenile mice [18]. This study evaluated transcriptional
effects in animals in which TH production had been
severely depressed through a relatively long-term treat-
ment with a high concentration of an antithyroid drug
(6-propyl thiouracil (PTU)). This model proved ineffi-
cient for the identification of genes directly regulated by
TH as the lengthy period of treatment with antithyroid
substance prevented a clear interpretation of the mode
of action for altered genes. It was unclear if altered gene
expression was caused by direct TH action, or due to
downstream effects in the liver resulting from an altered
developmental trajectory.
There is overwhelming evidence that environmental
contaminants can act as endocrine disrupters with pos-
sible negative consequences for human health. However,
major needs in the field include the identification of key
initiating events leading to impaired development and
tissue function. In the current study, we apply a well-
validated animal model and robust microarray analysis
to investigate hepatic transcriptional response to transi-
ent hyper- and hypothyroidism. The transient treatment
time in combination with conditions of both hyper- and
hypothyroidism provide a more efficient approach to
identify direct hepatic targets of THs during liver
development. In addition to identifying key genes that
are directly controlled by THs, the work sheds light on
the TRE sequences that direct TR binding. To identify
TH targets, livers were collected from juvenile mice
(postnatal day (PND) 15) rendered transiently hypo- or
hyperthyroid. This developmental period corresponds to
a dramatic increase in circulating THs. In PND 15 mice,
circulating T4 is higher than at any other age [20] sug-
gesting that chemically-induced disruption of TH levels
should cause a marked response in transcription. Using
DNA microarrays, we identify genes that are differen-
tially expressed between control and TH-modulated ani-
mals, and provide supporting evidence for the presence
of TREs in the regulatory regions of several of these
genes. Collectively, the results provide an important
addition to general knowledge of the genes that are
directly regulated by THs and are useful for defining an
improved TRE consensus sequence.
Methods
Animals and Exposures
All animal care and handling was in accordance with
Canadian Council for Animal Care Guidelines and was
reviewed by the Health Canada Animal Care Committee
prior to commencement of the study.
C57BL/6 mice were purchased from Charles River (St.
Constant, QC, Canada) and were housed in hanging
polycarbonate cages under a 12:12 hr light-dark cycle at
23°C. Animals were provided with shelters, nesting mate-
rial, food ad libitum (Purina rodent chow 5010; Ralston-
Purina, St. Louis, MO, USA) and drinking water contain-
ing 1% (wt/vol) sucrose (ad libitum). Mice were accli-
mated for 10 days. Breeding was accomplished by
transferring two sexually mature female mice (eight
weeks post natal) into the home cage of a sexually mature
(10 weeks post natal) male. After four nights of co-hous-
ing, each female was transferred to a separate cage. Dams
were allowed to litter naturally and pup numbers were
not adjusted. To produce hypothyroid (hypo) pups, dams
were provided with drinking water that contained methi-
mizole (MMI, 0.05% wt/vol) and perchlorate (1% wt/vol)
for three days (PND 12 to 15). To produce hyperthyroid
(hyper) pups, intraperitoneal injections (i.p.) of THs (50
μgo fT 4+5μg of T3 per 100 g body weight) were admi-
nistered to pups on PND 15, four hours before decapita-
tion and tissue collection. For the hypothyroid/
replacement group (hypo+); dams were provided with
drinking water that contained MMI (0.05% wt/vol) and
perchlorate (1% wt/vol) for three days (PND 12 to 15).
Pups then received i.p. injections of THs (20 μgo fT 4+2
μg of T3 per 100 g body weight) on PND 15, four hours
before decapitation and tissue collection. The control
and hypo groups received saline i.p. injections four hours
before decapitation and tissue collection.
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On PND 15, pups were sacrificed by decapitation.
Serum prepared from trunk blood using serum separa-
tor tubes (BD Biosciences, Mississauga, ON, Canada)
was used for T4 analyses by radioimmunoassay (RIA)
kits (MP Biomedicals, Medicorp, Montreal, QC, Canada)
as per the manufacturer’s instructions. The hypo +
group was subdivided into two sub groups - hereafter
called hypo+ and hypo++ - based on measured serum
T4 levels. Animals allotted to the hypo++ group had
serum T4 levels that approximated those seen in the
hyperthyroid group while those that remained as hypo+
had T4 levels near or slightly in excess of control levels.
Pup livers were rapidly dissected and flash frozen in
liquid nitrogen. Total RNA was extracted from liver
samples with TRIzol reagent (Invitrogen, Burlington,
ON, Canada) followed by RNeasy Mini Kit (Qiagen,
Missisauga, ON, Canada) clean-up according to the
manufacturer’s instructions. RNA quality assessment
was determined by Nanodrop (Thermo Scientific, Biller-
ica, MA, USA) and Agilent 2100 Bioanalyzer and RNA
6000 NanoLab Chip Kit (Agilent Technologies, Missis-
sauga, ON, Canada). All samples had 260/280 ratios
over 2.1, and RNA integrity numbers over 9.0.
Microarray Hybridization
Hepatic gene expression was assessed by hybridizing
samples to Agilent 4 × 44 k Whole Genome Microar-
rays (G4122F) using a reference design (details below).
Briefly, 200 ng of total RNA from the liver was used to
synthesize double-stranded cDNA and cyanine labelled
cRNA. Experimental samples were labelled with Cyanine
5-CTP and reference RNA (universal mouse RNA; Agi-
lent Technologies) with Cyanine 3-CTP (Perkin-Elmer
Life Sciences, Woodbridge, ON, Canada) according to
the manufacturer’s instructions (Agilent Linear Amplifi-
cation, Agilent Technologies). Cyanine labelled cRNA
targets were in vitro transcribed using T7 RNA poly-
merase and purified using RNeasy Mini Kit (Qiagen).
Experimental and reference samples (825 ng each) were
hybridized to arrays at 60°C for 17 hours. Slides were
washed and scanned on an Agilent Microarray Scanner
(G2565CA). The data were acquired using Agilent Fea-
ture Extraction software version 10.1.1.1. Prior to statis-
tical analysis, the scans were inspected using the Agilent
Quality Control report as well as an internal quality
control metric including spike-in RNA controls.
Experimental Design and Statistical Analysis of Microarray
Data
The Agilent 4 × 44 k Whole Genome Microarray features
four sub-arrays per slide. A reference design [21,22] with
sub-arrays as blocks of size two (each block containing
the corresponding reference: Cy3 = green, and sample:
Cy5 = red channels) was used to analyze the median sig-
nal intensities of the two-color microarray data. The
experiment included the main effects of treatment groups
(four conditions: hyper, hypo, hypo+, and one control)
plus the sub-array as a block term. Five biological repli-
cates per condition were used for three of the four
groups, while four replicates were used for the remaining
hypo+ condition (due to a shortage of animals with suita-
ble serum T4 levels in that group), yielding a total of 19
microarrays. An identical experimental structure was fol-
lowed for each gender. Separate statistical analyses were
carried out for the male and female samples, respectively,
to eliminate any correlation effect due to the dam as
samples within genders were independent.
All pre-processing of the data was conducted using R.
The data were normalized using loess normalization
[23] in the R library “MAANOVA”. Background fluores-
cence was measured using the (-)3xSLv1 negative con-
trol probes; probes with median signal intensities less
than the trimmed mean (trim = 5%) plus three trimmed
standard deviations of the (-)3xSLv1 probes were flagged
as absent (within the background signal). Ratio intensity
plots (also known as MA plots) were constructed for
the raw and normalized data for each array. Boxplots
and hierarchical clustering using average linkage were
generated to identify outlier arrays [24]. Two outlier
microarrays were removed from each data set (two
microarrays from male samples and two from female
samples) based on separate hierarchical clustering of
each dataset into sample = Cy5 and reference = Cy3
groups. As a result, the final analysis was based on 17
microarrays for females, and 17 for males.
Genes that were up- and down-regulated in any of the
three treatment groups (hyper, hypo, and hypo+) relative
to control were identified using the R library “MAA-
NOVA” [25]. The required ANOVA model was fitted to
include the main effects of dose plus the sub-array as a
block term. The Fs statistic [26], a shrinkage estimator,
was used for the gene-specific variance components, and
the associated p-values for all the statistical tests were
estimated using the permutation method (30,000 per-
mutations with residual shuffling). These p-values were
then adjusted for multiple comparisons using the false
discovery rate (FDR) approach [27]. All data are avail-
able through the Gene Expression Omnibus (GEO) web-
site, accession number: GSE21307.
The least squares mean [28,29], a function of the model
parameters, was used to estimate the fold-change for
each pairwise comparison of interest (control versus each
of the three treatment groups: hyper, hypo, and hypo+.)
Bioinformatics
Promoter regions (-8 kb to +2 kb relative to the tran-
scription start site (TSS)) of genes whose expression
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loaded from the UCSC Genome Browser (mm9 assem-
bly). Using a list of validated mouse TREs gathered from
the literature, a position weight matrix (PWM) was
developed to score the information content (bits) for
position one to six of TRE half-sites. In this way, each
TRE half-site was assigned a ‘score’ against the PWM.
The score for each TRE half-site was obtained iteratively
by leaving the subject out of the PWM construction.
Previous bootstrapping analysis of the validated TREs in
mice revealed a difference (p < 0.001) between the dis-
tribution of scores for the two half-site scores. Cross-
validation of the TREs from the literature was carried
out with each half-site analyzed separately. This analysis
revealed that a low threshold score (i.e., ≥ 3.76 bits) for
one half-site and a high threshold score (i.e., ≥ 6b i t s )
for the second half-site (regardless of half-site order)
allowed minimization of type I and type II errors
(manuscript in preparation). We therefore used the cut-
off scores identified in this cross-validation exercise and
scanned the promoter regions for putative TREs. The
scan searched for three different types of TREs: direct
repeats with a four nucleotide spacer (DR4); inverted
repeats with no spacer (IR0); and everted repeats with a
spacer of six nucleotides. (ER6).
Orthologs in humans and in rats were matched using
BioMart http://www.biomart.org for the genes that were
identified as having potential TREs in mice. Promoter
r e g i o n s( d e f i n e da s- 8t o+ 2k bo ft h eT S S )f o rt h e s e
orthologous genes were obtained. A local alignment
using a sliding window principle was used to align the
TREs identified in mice to the promoter regions of the
corresponding orthologous genes in rats and humans. A
modified substitution matrix favouring conservation of
the guanine in position two and three of the TRE hex-
amer half-sites was used, since these two sites appear to
be highly retained. Three additional features were used
to filter identified TREs: i) a maximum mismatch of two
when comparing mouse to rat, and mouse to human, ii)
a maximum distance of 2 kb between TREs when com-
paring mouse to rat and mouse to human, and iii) a
minimum score determined by the PWM scan.
Gene Ontology Analysis and Principal Component
Analysis
Genes with FDR corrected p-values smaller than 0.05 in
at least one experimental condition were used for prin-
cipal component analysis (PCA) and pathway/ontology
analysis. PCA was carried out using mean centering and
scaling on data from genes that were significant in at
least one treatment group using Genespring GX 7.3.1
(Agilent Technologies). Mean fold-change, averaged
across all replicates per sex per treatment, was subjected
to functional enrichment and Gene Ontology (GO)
analysis using Ingenuity Pathway Analysis (Ingenuity
Systems Inc., Redwood, CA, USA).
Real-Time Quantitative PCR Analysis
Total RNA was reverse transcribed into cDNA using
SuperScriptIII (Invitrogen) as per the manufacturer’s
instructions. iQ SYBR Green Supermix (BioRad Labora-
tories, Mississauga, ON, Canada) was used with a reac-
tion volume of 50 μL. All primers were designed using
Beacon Designer 7 (Premier BioSoft International, Palo
Alto, CA, USA). Hprt was used as the reference gene.
Microarray analysis and RT-qPCR analysis confirmed
that Hprt expression was stable across all groups. Reac-
tions were carried out in 96-well plates. PCR were done
in duplicate and each plate contained all samples for the
gene of interest and reference gene for one sex. Analysis
was carried out using a CFX96 Real-Time PCR Detec-
tion Systems (BioRad Laboratories). Melting curves were
performed for each reaction to ensure primer specificity.
Raw data were up-loaded into Relative Expression Soft-
ware Tool 2009 (REST 2009; Qiagen). where fold-
changes and p-values were calculated.
ChIP-PCR
Livers from the male euthyroid control group were used
for the ChIP using the EZ ChIP kit (Millipore Corpora-
tion, Toronto, ON, Canada), according to the manufac-
turer’s instructions. Briefly, a small piece of liver was
homogenized with a hand-held homogenizer in 250 μL
PBS containing broad-spectrum protease inhibitors, and
was then cross-linked with 1% formaldehyde. Cross-link-
ing was stopped with glycine and nuclei were collected
by adding lysis buffer. To ensure that DNA fragments
ranged from 200 to 600 bp, the nuclear solution was
sonicated in an ice bath with 30 second bursts at 28%
amplitude. Fifteen bursts were completed, each separated
by a 60 second period. DNA fragment size was verified
by agarose gel electrophoresis. Six percent (about 100
μL) of the sonicated solution was stored at -20°C as total
input (TI), while the remainder was incubated with anti-
TRb polyclonal antibody (PA1-213, clone TRb-62, Affi-
nity BioReagents, Golden, CO,U S A )o v e r n i g h tw i t ha g i -
tation at 4°C. Antibody-bound chromatin was
precipitated with Protein G conjugated agarose beads,
washed with gradient stringent buffers, and eluted with
elution buffer as per the manufacturer’s instructions.
Both the eluted solution and the stored TI were incu-
bated at 65°C overnight to reverse cross-links. Immuno-
precipitated (IP) DNA and TI DNA were purified by
treatment with RNase, proteinase K and multiple phenol:
chloroform:isoamyl alcohol (25:24:1) extractions. Equiva-
lent amounts of IP DNA and TI DNA were amplified in
parallel, using a random primer method with Genome-
Plex Complete Whole Genome Amplification Kit
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was then purified using GenElute PCR Clean-Up kit
(Sigma-Aldrich).
Primers targeting the TRE identified by bioinformatics
analysis were designed using Beacon Designer 7. PCRs
were performed using Expand High Fidelity PCR System
(Roche, Laval, QC, Canada). b-actin (NM_007393.3) was
used as a negative control and Mlxipl (NM_021455.3)
was used as a positive control [30]. Gel analyses and
band quantifications were carried out using GeneTools
(Syngene, Frederick, MD, USA). Binding ratios were cal-
culated by dividing the ratio of IP/TI from the gene of
interest by the ratio of IP/TI from the reference gene b-
actin. Mean enrichment, standard deviations, and p-
values were calculated using log ratios and were then
back-transformed.
Electrophoretic Mobility Shift Assays
Probes were designed against the specific genomic
regions of the newly identified TREs. Probe size ranged
between 26 and 30 bp. The probe contained the putative
TRE sequence plus six to seven nucleotides on each
side. Oligonucleotides were labelled using Biotin 3’ End
DNA Labeling Kit (Thermo Scientific) as per the manu-
facturer’s instructions and were then annealed. Binding
reaction and detection of complexed biotin-labeled
DNA-protein was accomplished using the LightShift
Chemiluminescent EMSA Kit (Thermo Scientific) as per
the manufacturer’s instructions. Binding reactions were
carried out in 20 μL volumes and had final concentra-
tions of 2.5% glycerol, 5 mN MgCl2,5 0n g / μLP o l y
(dI￿dC) and 0.05% NP-40. One μgo fc h i c k e nT R a
(Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA)
was used per reaction. An amino acid alignment of the
TRa DNA-binding domains from Mus musculus and
Gallus gallus showed an approximate 98% sequence
homology. Amino acids involved in direct base contacts
[31] were specifically examined and were not found to
be substituted between species. We have previously
found that TRa and TRb interact with TREs in a very
similar manner [18]. Amino acid alignment of DNA-
binding domains showed an approximate 86% sequence
homology between the TR isoforms. Amino acids
involved in direct base contacts [31] were specifically
examined and showed 100% conservation between the
two isoforms.
Biotin end-labelled target DNA was diluted 1:4 and 2
μL were used per reaction. Unlabeled probes were used
at a 200-fold molar excess compared to labelled probe.
For the supershift, 2 μgo fa n t i b o d yT R a/b (Santa Cruz
Biotechnology Inc.) or normal mouse IgG (Santa Cruz
Biotechnology Inc.) were used per reaction. Samples
were run on a 5% polyacrylamide gel, transferred onto
Biodyne Precut A Nylon Membranes (Thermo
Scientific) by electrophoretic transfer and UV-cross-
linked. Membranes were scanned using ChemiDoc XRS
+ (BioRad Laboratories) andi m a g e sa n a l y s e du s i n g
Image Lab version 2.0.1 (BioRad Laboratories)
Results
Validation of the MMI/sodium Perchlorate Mouse Model
Serum T4 levels in all PND 15 pups were measured
(Figure 1). A significant increase was observed in the
hyper pup group compared to control levels, whereas a
significant decrease was observed in the hypo pup
group compared to control levels. The hypo+ and hypo
+ +p u pg r o u p sa l s os h o w e das i g n i f i c a n ti n c r e a s ei n
serum T4 compared to control. The hypo++ pup group
received the same doses of THs in the i.p.i n j e c t i o na s
the hypo+, but registered higher levels of circulating
T4 (levels similar to the hyperthyroid pup group).
Levels of T4 in hyperthyroid and hypo++ groups were
not significantly different. Part of this data has already
been reported [32].
Genes Significantly Altered by TH Perturbations
MAANOVA analysis identified approximately 400 sig-
nificantly altered genes in male and/or female pups,
with a FDR-adjusted p < 0.05 in at least one of the
treatment conditions (see Additional File 1 for male
data and Additional File 2 for female data). Fold-
changes ranged from 1.1 to 13.8, and averaged approxi-
mately 1.6. In hypo mice, 215 genes were significantly
altered relative to euthyroid controls. Of these, tran-
scription levels of 118 genes were reduced and 97 were
increased in hypo livers relative to controls. In the
hyperthyroid group, 204 genes were significantly altered.
Of these, transcript levels of 45 genes were reduced and
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Figure 1 PND 15 pup serum T4 levels after short-term TH
perturbation. Means are presented as well as ± standard
deviations. n = 10, 5 from each sex, for control, hyper and hypo; n
= 8, 4 from each sex for hypo+; n = 5, males only for hypo++. All
treatment groups when compared to controls were significantly
different; p ≤ 0.05, determined by student t-test.
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group, 68 genes were significantly altered with 14
reduced and 54 increased. Females exhibited more sig-
nificantly altered genes than males. Females had 300 sig-
nificantly altered genes whereas males had 185. A
comparison of these two lists revealed that there were
100 genes that were differentially expressed by at least
one treatment condition in both females and males (i.e.,
100 genes in common between the sexes).
Using the full set of significant genes (FDR-adjusted p
< 0.05) for all groups (control, hyper, hypo and hypo+),
a principal component analysis (PCA) was conducted
(Figure 2). This analysis revealed that expression pat-
terns were highly correlated within sexes and treatment
groups. The PCA revealed distinct male and female
clusters (Figure 2A) and four clusters were also found to
separate control, hyper, hypo and hypo+ groups. Thus,
the expression profiles reveal both an overall treatment
as well as sex effect, with both sexes showing similarities
in their response within treatment groups.
The list of all significant genes was subjected to GO
and pathway analysis. The analysis revealed several path-
ways that were significantly altered by the treatment.
The five most affected pathways are presented in Addi-
tional File 3, along with the names of the genes that
were affected by TH treatment within the pathway.
Many genes were found to be involved in oxidative
stress response and xenobiotic metabolism/signalling. A
group of genes involved in TR/RXR activation was also
identified.
By comparing the response profile of genes that were
significantly altered in the hyper, hypo and hypo+
groups, we identified a subset of genes that are most
likely to be directly regulated by TH rather than by
downstream effects. For example, a directly regulated
gene would be expected to show similar responses in
the hyper and hypo+ groups, and should be in the
opposite direction to the hypo group. The hypo+ group
is particularly informative, as these animals were sacri-
ficed four hours after a single injection of TH, but fol-
l o w i n gam o r ep r o l o n g e ds t a t eo fh y p o t h y r o i d i s m .I n
addition, genes showing similar responses in hypo and
hypo+ groups would be less likely to be directly regu-
lated by TH. Genes showing a pattern suggesting direct
regulation by TH are listed in Table 1.
Microarray Data Validation and Hypothyroid Replacement
Analysis
Microarray data were validated using real time RT-qPCR
for subsets of significantly altered genes (FDR p < 0.05).
0
1
0 1
Y
Z
0 1
0
1
Z
X
0
1
0
1
X
Y
0 1
0
1
X
Y
0
1
0
1
Y
Z
0
1
0 1
Z
X
A. B.
Figure 2 Principal component analysis of microarray data carried out with the full set of significant genes (FDR-adjusted p ≤ 0.05) for
all groups (control, hyper, hypo and hypo+). Data are coloured by sex (A) and by treatment group (B). In panel (A) male data points are in
red and female data points are in yellow, and in panel (B) control data points are in yellow, hypothyroid data points are in red, hyperthyroid
data points are in cyan and hypothyroid/replacement (hypo+) data points are in fuchsia.
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have previously been shown to be directly regulated by
TH (Thrsp, Dio1 and Me1; Table 2). Some of these genes
were only significant with RT-qPCR (e.g. Dio1 in hyper
males and females was not identified as differentially
expressed on the microarray; Table 2). Thus, the data
produced by the microarray analysis are likely to be con-
servative, and include some false-negatives.
Second, we validated several genes suspected of being
directly regulated by TH using RT-qPCR. For this analysis,
we compared gene expression changes in the four treat-
ment groups, as well as in a group of animals subjected to
the hypo+ treatment but whose circulating T4 levels were
substantially higher than those in the hypo+ animals used
for microarray analysis (i.e., the hypo++ group). Here we
present the results from the hypo+ and hypo++ groups
when compared to control data (Table 3). The direction of
Table 1 Genes identified as being directly regulated by
THs.
Hypo Hyper Hypo+
Accession Gene ♂♀♂♀♂♀
NM_027980 2310003H01Rik 1.4 1.4 1.3
AK014609 4633401B06Rik 1.4 1.6 1.7
AK044145 AK044145 2.6 2.7 2.1 1.9
NM_025404 Arl4d 2.0 2.0
NM_177047 Auts2 * 3.1 3.0 2.5 2.5
NM_145603 Ces2 1.5 1.4 1.5
NM_134141 Ciapin1 1.4 1.4 1.3
NM_026424.3 Coq10b 1.5 2.0
NM_001025384.3 DXBay18 -1.7 2.2 1.7 2.6 2.3
NM_175266 Epm2aip1 1.3 1.3 1.3
NM_008058 Fzd8 1.8 1.5 1.6
NM_153528 Gramd1c 1.6 1.7 1.4
NM_175244 Hectd3 1.3 1.4
NM_010544 Ihh * -1.2 -1.2
NM_008358 Il15ra 1.2 1.3
NM_178701 Lrrc8d 1.6 1.4 1.6
NM_172821 Map3k13 1.6 1.7
NM_027418 Mapk6 1.3 1.4 1.3
NM_027997 Serpina9 * -1.7 -1.9
NM_008018.4 Sh3pxd2a 1.7 1.7 1.5 1.5
NM_134154 Slc25a45 * -1.7 -1.6 1.7 1.9 1.5 1.6
NM_172463 Sned1 * -1.6 -1.6 1.5 1.5 1.5 1.4
NM_001081103 Stim2 1.9 2.0 1.5
NM_173038.2 Tbcel 1.3 1.3 1.3 1.4
NM_144884 Tor1a 1.2 1.3
NM_145076 Trim24 * -1.4 -1.6 1.6 1.4 1.5
NM_153162 Txnrd3 1.2 1.3
XM_001481284 Wipf3 -1.4 1.4 1.3
Fold-changes for males and females are presented in comparison to control
animals. All fold-changes have an adjusted p ≤ 0.05. Asterisks (*) denote
genes that were analysed by RT-qPCR. See Additional File 1 and 2 for p-value
data.
Table 2 Microarray and RT-qPCR results for known TH-
regulated genes.
Microarray RT-qPCR
Gene Group FC p-value FC p-value
Male Pups
Thrsp Hypo -2.8 0.036 -5.0 0.032
Hyper 1.6 0.999 2.4 0.170
Dio1 Hypo -2.6 0.000 -4.9 0.015
Hyper 1.3 0.999 1.5 0.029
Me1 Hypo -1.4 0.379 -1.4 0.099
Hyper 1.3 0.632 1.5 0.017
Female Pups
Thrsp Hypo -2.7 0.000 -5.0 0.033
Hyper 2.4 0.019 4.6 0.010
Dio1 Hypo -3.2 0.000 -7.8 0.001
Hyper 1.2 0.983 1.5 0.008
Me1 Hypo -1.4 0.045 -1.3 0.143
Hyper 1.3 0.095 1.7 0.002
Fold-changes are presented for treated animals relative to control animals; n
= 4 for all groups except for hyper, where n = 5. Fold-changes (FC) and p-
values are in bold when p ≤ 0.05.
Table 3 Microarray and RT-qPCR results for the male
hypo+ and male hypo++ treatment groups.
Microarray RT-qPCR
Gene Group FC p-value FC p-value
Slc25a45 Hypo+ 1.5 0.000 1.6 0.314
Hypo++ 2.4 0.000
Hectd3 Hypo+ *1.4 0.000 *2.4 0.026
Hypo++ 1.7 0.005
H01Rik Hypo+ 1.3 0.026 2.8 0.011
Hypo++ 1.4 0.008
Tor1a Hypo+ 1.3 0.026 1.6 0.117
Hypo++ 1.1 0.501
Auts2 Hypo+ 2.5 0.000 5.3 0.006
Hypo++ 5.6 0.002
Serpina9 Hypo+ *-1.9 0.000
Hypo++ -5.0 0.000
Sned1 Hypo+ 1.5 0.000 2.4 0.027
Hypo++ 2.4 0.041
Trim24 Hypo+ 1.5 0.000 2.9 0.398
Hypo++ 1.5 0.352
Ihh Hypo+ *-1.2 0.047
Hypo++ -2.0 0.041
The hypo++ group was not included in the microarray analysis. The fold-
changes represent treated relative to control animals; for RT-qPCR data n = 5
for each group. Fold-changes (FC) and p-values are in bold when p ≤ 0.05.
Asterisks (*) denote that the data were taken from female pups due to the
absence of significant data from male pups. H01Rik corresponds to
2310003H01Rik. Absence of data for RT-qPCR values were because of
undetectable signal due to low expression level.
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each of the nine genes selected for RT-qPCR validation. A
significant fold-change in the hypo++ group was observed
in all genes evaluated except for Tor1a and Trim24.
Bioinformatics Analysis of Direct TH-Regulated Genes
A search for TREs in the 28 regulatory regions of genes
suspected to be under direct TH-regulation (Table 1)
identified 196 TREs in 24 different genes. When locally
aligned with the rat promoter region of the correspond-
ing orthologs, the list was reduced to 68 TREs in 20 dif-
ferent genes. Once this was accomplished, the
remaining TREs were locally aligned with the human
promoter region of the corresponding orthologs to pro-
duce the final list of 33 TREs found in 13 different
genes (Table 4). The candidate TRE sequences in rats or
h u m a n sw e r ew i t h i n2k bo ft h er e l a t i v ed i s t a n c eo ft h e
putative TRE identified in mice, and had two or less
Table 4 TREs identified using bioinformatics searches of promoter regions of genes characterized as being directly
regulated by THs.
Mouse Rat Human
Gene Type Pos. TRE Pos. TRE MM Pos. TRE MM
H01Rik
‡ DR4 1597 GGGTCACCAGGGGCTA 1513 GGGTCACCAGGGGCTA 0 1709 GGGTCACCAGGGGCTG 1
H01Rik
‡ DR4 -5778 AGGGCAGCAGAGCTGA -5806 AGGGCAGCAGGGCTGA 1 -7091 AGGGGCAGGCAGCTGA 1
-4046 AGGGAAAGACAGCTCA 2
H01Rik
‡ DR4 281 AGGTCAGGCGAGGGCA 243 AGGTCAGGCGAGGGCA 0 1176 TGGTCAGGCCTGGGCA 2
H01Rik
‡ IR0 -2311 AGGTGAAGCCCT* -2421 AGGTGAAGCCCT 0 -3415 CGGTGAAACCCT 2
Arl4d DR4 -2529 AGGCCAGCCAGGGCTA -1594 AGGCTAGCCTGGGCTA 1 -1286 AGGCCTCAAAGGGCTT 2
-922 AGGCCGATGTGGGCGA 2
Ces2 DR4 -5950 AGGCAAAGCAAGGTCT -7139 AGGCAACTGCAGGTTT 1 -7548 AGGCAAAAGCTGGGCT 2
-7219 TGGCAATCTGAGCTCT 2
-4185 AGCTAAGCCAAGGTCT 2
Fzd8 DR4 -143 CGGTCACCCCAGGAGA 6 CGGTCACCCCAGGAGA 0 399 CGGTCGGGCCAGGCGA 2
Hectd3 ER6 -7433 TGGCCTGAAGATAGGACA* -6784 TGGCCTCTCCTATGGACA 1 -7570 TGGCCTACAACCAGGATA 1
-6806 GGGCCAATGCTCAGGACA 2
Hectd3 DR4 -3516 AAGTCACCTGAGGAGA -5475 AAGTCACCTGAGGAGA 0 -2992 AAGTCATTTGGGGAAA 2
Ihh ER6 -5766 TGACCTTTATGCAAGTCA -6131 TGACCTTTATTCAAGTCA 0 -4898 CCACCTCTGTTCAAGTCA 2
Serpina9 DR4 31 AGGACAACAAGGGCGA 31 AGGACAACAAAGGCGA 1 167 AGGACAGGGCAGGAGA 2
Slc25a45 DR4 -4642 AGGATTTCTAAGGCCA* -5175 AGGATTTCTATGGCCA 1 -6373 AGGTTTGCAATGGCCA 2
Sned1 DR4 409 AGGTGGAATGAGGACA 317 AGGTGGAATGAGGACA 0 332 AGGTGGAATGAGGACA 0
-864 AGGTGGGGGCAGGACT 1
Sned1 ER6 217 TCACCCCGAAGCAGGACG 125 TCACCCCGAAGCAGGACG 0 125 TCACCCCCAAGCAGGACG 0
Tbcel DR4 15 GGGTCAGCATAGGACA -7 GGGTCAATGCAGGACA 01 5 GGGTCAATGCAGGACA 0
Tbcel IR0 920 AGGACAAGTCCC 891 AGGACAAGTCCC 0 649 AGGACATGTCCC 1
1157 GGGACAAGCCCC 2
470 GGGACCAGTCCC 2
Tbcel DR4 1361 AGGCCAGCCTGGGCTA 1371 AGGCCAGCCTGGGCTA 0 -230 AGGACAATAGGGGCTG 2
Tor1a DR4 -2364 AGGACAGCCAGGGCTA* -4242 AGGAAACACACGGCTA 2 -1610 AGGATACTCCGGGCTC 2
Tor1a DR4 1648 AGGTTAGTCTGGGCTA 1638 AGGTTAGTCTGGGCTG 1 552 CGGTTGGCTGGGGCTA 2
Tor1a DR4 -2729 AGGACAGCCAGGGCTA -4242 AGGAAACACACGGCTA 2 -1610 AGGATACTCCGGGCTC 2
Tor1a DR4 -4783 AGGCCACTTCAGGTTG -6425 AGGCCAGAAGAGGGTG 1 -6272 AGGCCAAGGCAGGAGG 2
-6628 AGGCCAGGCACGGTGG 2
Trim24 DR4 295 AGGACAATGGAGGTGG -5 AGGACAATGGAGGTGG 0 336 AGGACAATGGAGGTGG 0
Txnrd3 IR0 372 GGGTGATGATCT 362 GGGTTATGATCT 1 1423 GGGTGGTGATCT 1
1876 GGGTGATAACCT 2
Previously Characterized TREs
Klf9
a DR4 -3804 AGGTGAAGTGAGGTCA -3819 AGGTGGGGCGAGGTCA 1 -2875 AGATTGTCTGAGGTTA 4
Mbp
b ER6 -192 GGACCTCGGCTGAGGACA -138 GGACCTCGGCCGAGGACA 0
TREs were found to be conserved between mice, rats and humans (i.e., within 2 kb of the mouse TRE and with 2 or less mismatches (MM) when compared to
the mouse TRE). MMs were only considered in the bolded half-sites. Positions (Pos.) of the TREs are presented in reference to the transcription start site of the
associated gene. Two previously characterized TREs are presented at the bottom of the table. * TREs validated by ChIP-PCR.
‡ Corresponds to 2310003H01Rik.
a
Characterized by [40].
b Characterized by [41,42]; bolding of half-sites and positions of TRE were corrected.
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Page 8 of 15mismatches when compared to the mouse TRE. Thus,
this final list of 33 TREs provides the most likely candi-
date TRE-containing promoters that may be conserved
between mice, rats and humans.
ChIP-PCR Analysis
ChIP-PCR, using euthyroid livers, was performed to vali-
date TR-TRE binding of six TREs selected from the list
of genes thought to contain conserved TREs (Table 4).
TRb-1 antibody was used to precipitate the protein-
DNA complexes followed by PCR analysis to compare
TI (not precipitated) to IP samples. Antibody specificity
has previously been demonstrated [17]. Mlxipl was used
as a positive control as it binds TR in its promoter
region, whereas b- a c t i nw a su s e da san e g a t i v ec o n t r o l .
Mean enrichment of Mlxipl compared to b-actin is
shown as well as the individual enrichment of the three
biological samples (Figure 3A). TREs identified in the
promoter regions of Tor1a, 2310003H01Rik, Hect3d and
Slc25a45 were enriched by 4-fold or more in the IP
compared to TI (Figure 3B-E). Candidate TREs analysed
in the promoter regions of Ihh and Arl4d showed no
apparent enrichment in the IP samples (data not
shown).
Electrophoretic Mobility Shift Assays
EMSAs were used to demonstrate the ability of the sus-
pected TREs to bind to the TR. A DR4 containing two
perfect half-sites (AGGTCA) was used as a positive con-
trol and showed a shift in electrophoretic mobility and a
decrease in detection (30-fold decrease) when unlabelled
probe was added (Figure 4). The DR4 positive control
tested with an antibody against TRa/b exhibited a
decrease in signal (7-fold decrease) of the shifted bands,
and a slightly detectable supershifted band. In contrast,
the non-specific mouse IgG antibody showed no reduc-
tion in detection of the shifted bands. Probes with
sequences of suspected TREs associated with the genes
Slc25a45, Hectd3 and Tor1a all showed a shift in elec-
trophoretic mobility, as well as a decrease in detection
when unlabelled probe (24, 17 and 2.5-fold decrease,
respectively) or unlabelled DR4 positive control probe
(92, 68 and 20-fold decrease respectively) was added
(Figure 4). Thus, the EMSA results help to support the
idea that the TR can bind to putative TREs in the pro-
moter regions of Slc25a45, Hectd3 and Tor1a.
Discussion
To identify direct transcriptional targets of TH and
genes containing TREs, we produced global gene expres-
sion profiles in hypothyroid and hyperthyroid mouse
models established by short-term exposure to MMI and
perchlorate and/or TH injection. PND 15 livers were
studied as animals of this age have circulating T4 levels
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Figure 3 Relative enrichment of newly identified TREs
determined by ChIP-PCR. The top half of each section shows the
amplicons run on an agarose gel, and the bottom half shows
relative enrichment of the immunoprecipitated (IP) samples and the
total input (TI) samples when compared to b-actin enrichment.
ChIP-PCR validation of negative (b-actin) and positive (Mlxipl)
controls are presented in section (A). Sections (B) to (E) show
enrichment of Tor1a, H01Rik (2310003H01Rik), Hectd3 and Slc25a45.
Asterisks (*) denote a significant difference, p ≤ 0.05, determined by
student t-test. The mean enrichments (± standard deviations) are
also presented for each section. All presented immunoprecipitated
enrichments were significant (p ≤ 0.05 determined by student t-
test) when compared to total input, except for b-actin.
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Page 9 of 15higher than at any other age [20] and the liver is widely
studied as a model of TH action. In the hypo pups TH
levels were altered for three days, whereas in the
hyperthyroid pups TH levels were altered for four hours
immediately before tissue collection. Concentrations of
anti-thyroid agents used in the hypo exposure and con-
centrations of injected THs were not unusually high
when compared to other similar studies [17,33]. Several
hundred genes were responsive to this short-term treat-
ment, with fold-changes as high as 13.8. However, the
vast majority of these genes had relatively small fold-
changes (i.e., < 3-fold). When filtered on a 2.0 fold-
change cutoff, only 31 genes in females and 27 genes in
males were perturbed, with an overlap of 14 genes.
PCA confirmed that the microarray data clustered by
sex and by treatment type suggesting that there are sig-
nificant differences at the level of gene expression
between i) male and female pups and ii) control, hyper,
hypo and hypo+ pups. GO analysis identified multiple
pathways involved in oxidative stress and xenobiotic
metabolism/signalling, as well as confirming the enrich-
ment of genes in TR/RXR activation (Additional File 3).
The focus of the present research was to identify direct
TH-target genes, rather than conduct a detailed
mechanistic analysis. Thus, the data were mined specifi-
cally to identify direct TH-regulation and search promo-
ters for putative TREs.
As previously mentioned, studies characterizing TH
hepatic gene regulation have been carried out by others
[33-36] and by our group [18]. Although these studies
were carried out using different experimental designs,
animal models, and developmental stages, some impor-
tant similarities in molecular functions and processes
emerge including genes involved in TR and RXR activa-
tion (see Additional File 3). In addition, several specific
genes previously shown to be involved in TH hepatic
gene regulation, such as Me1, Thrsp and Dio1 were also
found in the current study. However, our study design
is unique relative to the other work described above
because it is a short-term transient perturbation in TH
that queries a specific developmental period to identify
immediately responsive genes. The overarching goal of
the work is to use a robust microarray analysis of gene
expression profiling coupled with a novel TRE search
algorithm to identify putative TREs. Thus, a detailed
functional analysis of the perturbed genes in this study
compared to the other studies has not been carried out.
To identify genes under direct TH-regulation we
examined the expression of a subset of responsive genes
in the hypo+ and hypo++ groups in detail. These groups
were rendered hypothyroid for the majority of the 3 day
exposure, and then received an i.p. TH injection four
hours before decapitation and tissue collection. In other
words, only a four hour period was allowed for tran-
scriptional response to the TH surge. Where the direc-
tion of the transcriptional fold-change in the hypo+
group was the same as in the hyper group, but the
opposite of the hypo group, we predicted that the gene
in question was under direct TH-regulation. Transcript
levels of some of these genes were analysed by RT-
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Figure 4 Examining the potential binding of candidate TREs by EMSA. The left panel shows results using a classic DR4 TRE with two
“AGGTCA” half-sites. The next three panels show gel shifts when using a probe targeting candidate TREs in the promoter regions of Slc25a45,
Hectd3 and Tor1a.
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Page 10 of 15qPCR in the hypo+ and hypo++ groups (Table 3). RT-
qPCR analysis confirmed a significant change in the
hypo+ group for four out of the nine genes relative to
vehicle controls. Analysis of the hypo++ group, which
registered a much higher level of circulating serum T4
compared to hypo+, showed that seven out of the nine
genes had significant fold-changes relative to control.
Validation of the transcriptional response in the hypo+
and hypo++ groups help to further support our assump-
tion that the identified genes (Table 1) are under direct
TH-regulation. None of the genes identified as being
directly regulated by THs have characterized TREs.
Although specific genes that are commonly considered
to be directly regulated by TH, such as Me1, Thrsp or
Dio1, were confirmed to be differentially regulated in
our experiment, they did not meet the stringent require-
ments set for this particular evaluation (i.e., our list of
potentially directly regulated genes; Table 1). As pre-
viously described, genes were considered to be directly
r e g u l a t e db yT Hi ft h e yf o l l o w e das p e c i f i ce x p r e s s i o n
pattern. Only genes exhibiting fold-changes with FDR-
adjusted p ≤ 0.05 were considered for this analysis.
However, the RT-qPCR analysis demonstrated that
known TH responsive genes were responding as pre-
dicted in the animal model used (Table 2).
We retrieved the relevant DNA sequences and identi-
fied potential TREs within the promoter regions of the
responsive genes (i.e., the genes in Table 1). We
assumed that genes under direct TH-regulation should
contain functional TREs in their promoter regions. For
practical reasons, our search was limited to the immedi-
ate promoter region (from 8 kb upstream to 2 kb down-
stream of the TSS) even though not all response
elements are located in this area. Some studies have
shown that transcription factor binding sites can be
exceptionally far from the chromosomal location of the
genes they regulate. For example, some estrogen
response elements (EREs) can be found 50 kb away
from of the TSS [37], whereas others can be more than
100 kb away from the TSS [38]. In addition, interchro-
mosomal regulatory interactions have also been docu-
mented [39]. Our gene expression profiling analysis
identified 28 genes that appeared to be under direct
TH-regulation. Within these 28 genes, bioinformatics
mining for three different types of TREs (DR4, IR0 and
ER6) revealed 196 candidate TREs. To help identify true
TREs, we carried out a local alignment of promoters of
these mouse genes with the promoter regions of Rattus
norvegicus and Homo sapien. In the -8 kb to +2 kb pro-
moter regions of these genes we were able to identified
33 TREs in 13 different genes. Thus, within the region
examined approximately 46% of the genes possessed
potentially conserved TREs that fall within the estab-
lished half-site criteria.
Conservation of a stretch of DNA between all three
species provides evidence of the selective importance
of response element functionality. Two previously char-
acterized TREs are presented at the bottom of Table 4.
The TRE near Klf9 has been characterized in mice,
rats, and humans [40]. Comparison of the TREs within
the orthologous Klf9 gene of the three species shows
that the TREs are within 2 kb of each other relative to
the TSS. The TRE located in the Mbp gene promoter
region has been characterized in mice and rats [41,42].
The TREs for Mbp for both species are within 2 kb of
each other relative to the TSS and show very good
half-site sequence conservation. Conservation of
response elements between species has been previously
observed. Similar to the current study, Bourdeau et al.
identified EREs in 660 different pairs of orthologs
between mice and humans [43]. EREs identified in
proximity of these orthologs were within 2 kb of their
respective TSSs. Some EREs that were conserved
between mice and humans were perfect matches,
whereas others had multiple mismatches in their two
half-site. EREs are very similar to TREs; they are both
made up of AGGTCA half-sites. The classic ERE orga-
nization is an IR3, where the two half-sites are
arranged in a palindromic organization separated by a
3b ps p a c e r .T h ec l a s s i cT R E ,o nt h eo t h e rh a n d ,i sa
DR4 with the two tandem repeated half-sites separated
by a 4 bp spacer [44], although IR0, ER6 and other
TREs have also been characterized. The similarities and
differences that exist between EREs and TREs suggest
that the underlying mechanisms that confer response
element specificity are much more complicated than
was once thought. A recent paper by Phan et al.p o i n t s
out some interesting findings about nuclear receptor
DNA recognition specificity [45]. The authors looked
at the half-site recognition for retinoic acid receptor
(RAR) and TR, which both bind to the AGGTCA half-
site sequences. It was once thought that the spacing
between half-sites was the only aspect that conferred
specificity [46-48] although the authors discovered that
there were other properties that played an important
role, which included naturally occurring non-consensus
half-sites, flanking sequences, and auxiliary proteins
produced by the cell. These additional properties make
the identification of response elements even more com-
plex, especially considering the high degree of degener-
acy of TREs; nevertheless, they are important to take
into consideration. It is also important to point out
that our model did not consider flanking sequences
and that the PWM was built with “known” TREs that
biased towards the AGGTCA classic DR4 organization.
We are hopeful that future response element search
tools will be more flexible and take additional details
such as those described above into consideration.
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that allow very little variation from the classic AGGTCA
half-sites. Search algorithms often only allow substitu-
tion of a position towards one specific base pair, for
example, position one of the half-site would only allow
for an A or a G. This is a very restricted approach since
TREs can be very degenerated and, based on previously
characterized TREs, position one (as well as other posi-
tions) could potentially have any of the four nucleotides.
Moreover, previous search algorithms often did not
allow substitutions to occur at all half-site positions and
often limited the number of “mismatches” when com-
pared to the classic AGGTCA TRE half-site. Our TRE
search algorithm was much more flexible when com-
pared to these other approaches, as the PWM scored all
possible TREs and applied a score based on the prob-
ability for a given base to be located at any position of
the half-site based on known functional TREs. A cut-off
value was applied to this criterion to minimize false-
positives. Since our approach allowed for a great deal of
half-site sequence variation, a filtering or refining step
was needed to reduce false-positives. We found that a
cross-species comparison was an effective method to
reduce the amount of false-positives, and also increases
the potential utility of the new TREs for future research
as they may be relevant in multiple species. Our method
allowed for a larger amount of variability and as a result
we identified new candidate TREs that contain some
features of the classic TRE, but are substantially
different.
C h I P - P C Rw a su s e dt ov a l i d a t es o m eo ft h eT R E s
identified by the bioinformatics search. Six candidate
TREs were considered for this validation work. Four
showed enrichment by TR-immunoprecipitation,
whereas the two others did not show enrichment. This
suggests that the FDR is approximately 33%, but our
sample size for this estimate is quite low. The lack of
identification of TREs in certain genes could be attribu-
ted to various factors. TREs could be present in the pro-
moter regions of genes thought to be directly regulated
by TH but are undetected by the bioinformatics tools
currently available (i.e., do not exhibit the classic charac-
teristics). Functional TREs have been described with a
high level of degeneration, multiple spacer sizes and var-
ious half-site organizations [18,49-52] with a structure
divergent from the models on which our identification
algorithm was based. Consequently our model may have
been too conservative to identify other functional TREs
in these genes. Alternatively, TREs may truly be absent
from the promoter regions of these genes. Expression
may be tied to TH action through intermediate regula-
tory mechanisms. Non-genomic actions of TH have also
been characterized [53], by which TH activation of
plasma membrane receptors induces signal transduction
pathways leading to various genomic or cellular
responses, although some claim that the non-genomic
effects of THs do not play a significant role during ver-
tebrate development [54]. MicroRNAs (miRNAs) could
also potentially regulate TH-mediated mRNA expres-
sion. We recently identified significant alterations in 40
different miRNAs in the livers of PND 15 hypothyroid
mice [32]. Lastly, within our list of significantly altered
genes (FDR adjusted p ≤ 0.05), several transcription fac-
tors are present, including Rarb,E s r 1a n dN r 3 c 1( s e e
Additional File 1 and 2). Thus, genes present within our
list may be under the control of other transcription fac-
tors that are directly regulated by THs. For example,
Esr1 expression is decreased in hypothyroid female
mice. This could lead to many downstream transcrip-
tional effects since Esr1 is a transcription factor that has
been shown to interact with 18 different nuclear recep-
tors (Nuclear Receptor Signaling Atlas, http://www.
nursa.org).
ChIP-PCR revealed significant enrichment for some of
the stretches of DNA thought to be involved in TR
interactions. TRs are thought to be bound in both pre-
sence and absence of THs, thus ChIP-PCR was only
performed with euthyroid animals. Importantly, the PCR
primers targeted a DNA fragment with an average size
of 168 bp which includes the putative TRE. In total,
four TRE sites were validated by ChIP-PCR. The TREs
identified in the promoter regions of Tor1a and
Slc25a45 correspond to a DR4 organization. The TRE
identified in the promoter region of Hectd3 corresponds
to an ER6 organization, whereas the TRE identified in
the promoter region of 2310003H01Rik corresponds to
an IR0 organization. The genomic locations of these
newly identified TREs all fall in upstream promoter
regions, -2.3, -4.6, -7.4 and -2.3 kb from their respective
TSS. Most TREs identified to date in the mouse genome
are located in upstream promoter regions, and more
then 70% are within the 0 to -2.5 kb upstream region.
The TRE that is the furthest from a TSS that has been
characterized to date in mice is in the promoter region
Klf9, and is -3.8 kb from its TSS. This information is
b a s e do nt h e1 4m o u s eT R E st h a tw ew e r ea b l et of i n d
in the literature (list available on request). Since 50% of
the TREs we have characterized here are outside these
bounds, our findings suggest that TREs are not necessa-
rily found more often within the 2 or 3 kb upstream
promoter region. The TRE associated with
2310003H01Rik was not validated by EMSA. This could
be due to the fact that recombinant purified protein
samples were used, as opposed to tissue or cellular
extracts. Extracts would include other transcription fac-
tors, such as TR’s known heterodimer partner RXR,
which may be required for the DNA-protein interaction
to occur at a detectable level. In contrast, the TREs
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Page 12 of 15associated with Slc25a45, Hectd3 and Tor1a were vali-
dated by EMSA, each showing a shift in the presence of
TR proteins and a decrease in detection when unlabelled
probe or DR4 unlabelled probe was added. The addition
of unlabelled probe demonstrates the specificity of the
shifted band, whereas the addition of the unlabelled
DR4 probe demonstrates that the shifted band was
caused by an interaction with the TR protein, since a
supershift using an antibody against TR was shown for
the DR4 positive control probe. A correlation between
the ChIP-PCR and EMSA results was observed.
S c l 2 5 a 4 5h a st h es t r o n g e s te n r i c h m e n tm e a s u r e db y
ChIP-PCR, followed by Hectd3 and Tor1a. Slc25a45
again showed the strongest decrease in signal intensity
when unlabelled specific probe was added in the EMSA,
followed by Hectd3 and Tor1a.
Slc25a45 is involved in the transportation of molecules
across the mitochondrial membrane [55]. THs have
been shown to induce mitochondrial biogenesis and
enhance ATP production [56]. The identification of a
TRE in the vicinity of the TSS of this transporter could
be an indication of its involvement in TH-dependant
mitochondrial biogenesis. Hectd3 is a ubiquitin ligase. In
humans, it has been shown to directly bind TARA, a
guanine nucleotide exchange factor involved in regulat-
ing actin cytoskeletal reorganization, cell mobility, and
cell growth [57]. THs have also been shown to play a
role in cytoskeletal protein regulation [58]. Thus, a TRE
in the promoter region of Hectd3 could link this gene
to cytoskeletal regulation via THs. In mice
2310003H01Rik is the predicted ortholog of FAAP100,
Fanconi anemia-associated protein, 100 kDa [59].
FAAP100 is involved in the Fanconi anemia (FA) core
complex, which plays a role in the DNA damage
response network [59]. FA is a genetic disease that
results from defects in proteins involved in DNA repair.
People affected by FA have physical anomalies, short
stature, and are predisposed to cancer arising from chro-
mosomal instability [60]. Children with FA have a high
risk of endocrine abnormalities including hypothyroid-
ism [61]. A recent study found that TH therapy could
improve the linear growth of children suffering from FA
[60]. The identification of a TRE in the promoter region
of 2310003H01Rik could shed light on the underlying
mechanisms leading to hypothyroidism in FA patients.
Tor1a is an adenosine triphosphatase. Mutation of this
gene has been linked to early onset dystonia and Parkin-
sonism [62]. Dystonia is a disorder characterized by sus-
tained muscle contractions often causing twitching and
repetitive movements or abnormal posture. THs are
important for proper muscle development and mainte-
n a n c e[ 6 3 ] .T h u s ,t h ep r e s e n c eo faT R Ei nt h ep r o m o -
ter region of Tor1a could suggest a potential role for
TH-Tor1a interaction in muscle development.
Conclusions
Using transcriptional profiling analysis we were been
able to identify genes suspected of being directly regu-
lated by THs in male and female mice. Bioinformatics
mining of the promoter regions of these genes revealed
33 candidate mouse TREs potentially conserved between
rats and humans. ChIP-PCR and EMSAs were employed
to validate the mouse TREs. We provide evidence of
four new TREs in the promoter regions of Tor1a,
Slc25a45, Hectd3 and 2310003H01Rik. The results pro-
vide data to develop a stronger model for the TRE
sequence motifs that direct TR binding, identify key
genes that may be important for TH mediated effects,
and help to further characterize the mechanisms by
which TH directly regulate gene expression.
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